Clinical Trial: A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143604) titled 'A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2' on Aug. 20.

Brief Summary: The purpose of this study is to measure the efficacy and safety of AZD0901 monotherapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma expressing CLDN18.2.

Study Start Date: Aug. 25

Study Type: INTERVENTIONAL

Condition: Gastric Cancer Gastroesophageal Junction Cancer

Intervention: DRUG: AZD0901

Participants will receive AZD0901 IV, Q3W

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca...